Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone

European Journal of Pharmacology

Volumn 406, Issue 3, 2000, Pages 325-332

  Zhang, Xianzhi ^a   Moilanen, Eeva ^a,b   Kankaanranta, Hannu ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apoptosis; Beclomethasone; Budesonide; Eosinophil; Fluticasone propionate

Indexed keywords

BECLOMETASONE; BUDESONIDE; CYTOKINE; DEXAMETHASONE; DNA; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; MIFEPRISTONE; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 5; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; APOPTOSIS; BECLOMETHASONE; BUDESONIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMAN; INTERLEUKIN-5; MIFEPRISTONE; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0034693075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00690-7     Document Type: Article

References (44)

1. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5
2. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation
3. The antiglucocorticoid action of mifepristone
4. Resolution of chronic inflammation by therapeutic induction of apoptosis
5. Pathophysiology of asthma
6. Efficacy and safety of inhaled corticosteroids. New developments
7. Early events in TNF signaling: A story of associations and dissociations
8. Pharmacology of corticosteroids
9. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics
10. New aspects of degranulation and fates of airway mucosal eosinophils
11. Lack of apoptotic airway tissue eosinophils, even in-steroid-treated allergic disease
12. Pharmacology of the eosinophil
13. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: Comparison with other glucocorticoids
14. Purification of human blood eosinophils by negative selection using immunomagnetic beads
15. Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: A 14-day dose-response study
16. Glucocorticoid receptors and fluticasone propionate
17. SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils
18. Human eosinophil isolation and the measurement of apoptosis
19. Delayed eosinophil apoptosis in asthma
20. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor
21. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
22. The airway anti-inflammatory effects of fluticasone propionate
23. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
24. The clinical pharmacology of fluticasone propionate
25. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium
26. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling
27. Apoptosis of eosinophils and lymphocytes in allergic inflammation
28. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
29. In vivo paradigms of diseased airway mucosa: Selected aspects of innate immunity and eosinophils
30. Eosinophil apoptosis in allergic diseases - An emerging new issue
31. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
32. An in vitro comparison of commonly used topical glucocorticoid preparations
33. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5
34. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro
35. Influence of inhaler systems on systemic availability, with focus on inhaled corticosteroids
36. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects
37. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI
38. Tumor necrosis factor-alpha mediates antiapoptotic signals partially via p38 MAP kinase activation in human eosinophils
39. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis
40. Cell death induction by receptors of the TNF family: Towards a molecular understanding
41. Glucocorticoids inhibit cytokine-mediated eosinophil survival
42. Mechanisms of human eosinophil survival and apoptosis
43. Eosinophil apoptosis and the resolution of airway inflammation in asthma
44. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils